Contichrom® CUBE
The Contichrom CUBE is a benchtop continuous chromatography system for process development of (bio-)pharmaceuticals. The five-in-one functionality includes single-column and integrated batch chromato...
YMC is a leading global provider of fine separations technology products and services for the purification of pharmaceutical and biopharmaceutical compounds. YMC’s business is centered around liquid chromatography as a full-range supplier of bulk packing materials, lab and production scale systems, and associated services. However, the company also has a long history in manufacturing unit operations, such as TFF, biosynthesis systems, and precision dilution systems that are engineered for the demanding applications in the production of regulated drug therapies.
The Contichrom CUBE is a benchtop continuous chromatography system for process development of (bio-)pharmaceuticals. The five-in-one functionality includes single-column and integrated batch chromato...
YMC’s portfolio of HPLC columns encompasses a wide range of phases and specifications across multiple modes of chromatography, allowing customers to choose the product that best suits their sample’s c...
YMC-Triart columns are well-suited to a variety of applications in pharmaceutical and chemical laboratories. Eight different phases are available, all trifunctionally bonded, in column sizes ranging...
YMC-Accura Triart columns deliver the proven strength and precision of YMC-Triart resins packed in bioinert columns.
YMC is a leading global provider of fine separations technology products and services for the purification of pharmaceutical and biopharmaceutical compounds. YMC’s business is centered around liquid chromatography as a full-range supplier of bulk packing materials, lab and production scale systems, and associated services. However, the company also has a long history in manufacturing unit operations, such as TFF, biosynthesis systems, and precision dilution systems that are engineered for the demanding applications in the production of regulated drug therapies.